EZH2 and esophageal squamous cell carcinoma: We validated EZH2 occupancy on the DMRs of the WNT2 promoter by performing chromatin immunoprecipitation sequencing (ChIP-seq) in normal immortalized esophageal epithelial cells (Het-1A) and the patient-derived ESCC cell line, EC109.